1) Antineoplastic 2) Antineoplastic drug 3) Cancer drug 4) Elspar 1) Elspar 
(from the article `drug`) Hydroxyurea inhibits the enzyme ribonucleotide reductase, an important element in DNA synthesis. It is used to reduce the high granulocyte count ...
A drug that is used to treat acute lymphoblastic leukemia (ALL) and is being studied in the treatment of some other types of cancer. It is an enzyme taken from the bacterium Escherichia coli (E. coli). It breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. Also called Elspar and L-asparaginase...
<drug, enzyme> An enzyme that hydrolyses L asparagine to L aspartate and ammonia that is used as an antitumour agent especially against lymphosarcoma and lymphatic leukaemia. ... (18 Nov 1997) ... 
(as-par´ә-jin-ās″) an enzyme that catalyzes removal of the amine group that results in breakdown of asparagine; used as an antineoplastic agent against cancers such as acute lymphoblastic leukemia in which the malignant cells require exogenous asparagine for protein synthesis.
Enzyme (EC 3.5.1.1) that hydrolyzes L-asparagine to L-aspartate and ammonia that is used as an anti-tumour agent especially against lymphosarcoma and lymphatic leukaemia.
Type: Term Pronunciation: as-par′ă-ji-nās Definitions: 1. An enzyme catalyzing the hydrolysis of l-asparagine to l-aspartate and ammonia. 2. The enzyme from Escherichia coli, used in the treatment of acute leukemia and other neoplastic diseases.
[n] - antineoplastic drug (trade name Elspar) sometimes used to treat lymphoblastic leukemia
Elspar noun antineoplastic drug (trade name Elspar) sometimes used to treat lymphoblastic leukemia
an enzyme that catalyzes the conversion of asparagine to aspartic acid and ammonia, used in the treatment of acute lymphocytic leukemia.